Literature DB >> 19181835

Insights into structure-activity relationships in the C-terminal region of divercin V41, a class IIa bacteriocin with high-level antilisterial activity.

Jitka Rihakova1, Vanessa W Petit, Katerina Demnerova, Hervé Prévost, Sylvie Rebuffat, Djamel Drider.   

Abstract

Divercin V41 (DvnV41) is a class IIa bacteriocin with potent antilisterial activity isolated from Carnobacterium divergens V41. Previously, we expressed from a synthetic gene, in Escherichia coli Origami, a recombinant DvnV41 designated DvnRV41, which possesses four additional amino acids (AMDP) in the N-terminal region that result from enzymatic cleavage and retains the initial DvnV41 activity. To unravel the relationship between the structure of DvnRV41 and its particularly elevated activity, we produced by site-directed mutagenesis eight variants in which a single amino acid replacement was specifically introduced into the sequence. The point mutations were designed to change either conserved residues in class IIa bacteriocins or residues specific to DvnV41 located mainly in the C-terminal region. The fusion proteins were purified from the cytosoluble fractions by immobilized affinity chromatography. DvnRV41 and its variants were released from the fusion proteins by enzymatic cleavage, using enterokinase. The purity of DvnRV41 and of the variants was checked by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, high-performance liquid chromatography, and mass spectrometry. The antibacterial activity of DvnRV41 and its variants was assessed using different indicator strains, including Listeria monocytogenes EGDe and Enterococcus faecalis JH2-2. The activity of all of the variants appeared to be less than the activity of DvnRV41. The decrease in activity did not appear to be related to a global conformational change, as determined by circular dichroism. Overall, the variants of DvnRV41 produced in the present study provide interesting insights into structure-activity relationships of class IIa bacteriocins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19181835      PMCID: PMC2663188          DOI: 10.1128/AEM.02266-08

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  57 in total

1.  A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.

Authors:  G Fimland; L Johnsen; L Axelsson; M B Brurberg; I F Nes; V G Eijsink; J Nissen-Meyer
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

Review 2.  Class IIa bacteriocins: biosynthesis, structure and activity.

Authors:  S Ennahar; T Sashihara; K Sonomoto; A Ishizaki
Journal:  FEMS Microbiol Rev       Date:  2000-01       Impact factor: 16.408

3.  Isolation of a Lactobacillus salivarius strain and purification of its bacteriocin, which is inhibitory to Campylobacter jejuni in the chicken gastrointestinal system.

Authors:  N J Stern; E A Svetoch; B V Eruslanov; V V Perelygin; E V Mitsevich; I P Mitsevich; V D Pokhilenko; V P Levchuk; O E Svetoch; B S Seal
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 4.  Bacteriocins: developing innate immunity for food.

Authors:  Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Nat Rev Microbiol       Date:  2005-10       Impact factor: 60.633

5.  Three-dimensional structure in lipid micelles of the pediocin-like antimicrobial peptide curvacin A.

Authors:  Helen Sophie Haugen; Gunnar Fimland; Jon Nissen-Meyer; Per Eugen Kristiansen
Journal:  Biochemistry       Date:  2005-12-13       Impact factor: 3.162

Review 6.  The continuing story of class IIa bacteriocins.

Authors:  Djamel Drider; Gunnar Fimland; Yann Héchard; Lynn M McMullen; Hervé Prévost
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

7.  Determination of essential and variable residues in pediocin PA-1 by NNK scanning.

Authors:  Tatsuya Tominaga; Yoshinori Hatakeyama
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

8.  Delineation of key amino acid side chains and peptide domains for antimicrobial properties of divercin V41, a pediocin-like bacteriocin secreted by Carnobacterium divergens V41.

Authors:  P Bhugaloo-Vial; J P Douliez; D Moll; X Dousset; P Boyaval; D Marion
Journal:  Appl Environ Microbiol       Date:  1999-07       Impact factor: 4.792

9.  Solution structure of carnobacteriocin B2 and implications for structure-activity relationships among type IIa bacteriocins from lactic acid bacteria.

Authors:  Y Wang; M E Henz; N L Gallagher; S Chai; A C Gibbs; L Z Yan; M E Stiles; D S Wishart; J C Vederas
Journal:  Biochemistry       Date:  1999-11-23       Impact factor: 3.162

10.  NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles.

Authors:  Fernando Porcelli; Raffaello Verardi; Lei Shi; Katherine A Henzler-Wildman; Ayyalusamy Ramamoorthy; Gianluigi Veglia
Journal:  Biochemistry       Date:  2008-04-26       Impact factor: 3.162

View more
  6 in total

1.  Effect of recombinant divercin RV41, structural variants and the activators of potassium channels on Listeria monocytogenes EGDe.

Authors:  J Rihakova; H Prevost; K Demnerova; D Drider
Journal:  Folia Microbiol (Praha)       Date:  2011-04-06       Impact factor: 2.099

Review 2.  Lactic Acid Bacteria (LAB) and Their Bacteriocins as Alternative Biotechnological Tools to Control Listeria monocytogenes Biofilms in Food Processing Facilities.

Authors:  Anderson C Camargo; Svetoslav D Todorov; N E Chihib; D Drider; Luís A Nero
Journal:  Mol Biotechnol       Date:  2018-09       Impact factor: 2.695

3.  Defining the structure and receptor binding domain of the leaderless bacteriocin LsbB.

Authors:  Kirill V Ovchinnikov; Per E Kristiansen; Gordana Uzelac; Ljubisa Topisirovic; Milan Kojic; Jon Nissen-Meyer; Ingolf F Nes; Dzung B Diep
Journal:  J Biol Chem       Date:  2014-07-03       Impact factor: 5.157

4.  In vivo activities of recombinant divercin V41 and its structural variants against Listeria monocytogenes.

Authors:  Jitka Rihakova; Jean-Michel Cappelier; Isabelle Hue; Katerina Demnerova; Michel Fédérighi; Hervé Prévost; Djamel Drider
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

Review 5.  A Review: The Fate of Bacteriocins in the Human Gastro-Intestinal Tract: Do They Cross the Gut-Blood Barrier?

Authors:  Leon M T Dicks; Leané Dreyer; Carine Smith; Anton D van Staden
Journal:  Front Microbiol       Date:  2018-09-28       Impact factor: 5.640

Review 6.  Class IIa bacteriocins: diversity and new developments.

Authors:  Yanhua Cui; Chao Zhang; Yunfeng Wang; John Shi; Lanwei Zhang; Zhongqing Ding; Xiaojun Qu; Hongyu Cui
Journal:  Int J Mol Sci       Date:  2012-12-06       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.